TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | 4 | -1 | -50 | -66 | -46 | -27 |
| S | %wins | 100 | 0 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/12/04 14:10 | 11/10/04 | INHX | Inhibitex Inc | Health | BioPrd | Biological Products, (No Diag | Alsop Stewart II | MD | T | P.d | 14,225 | 7.34 | 0 | 1,938 | 43 | 6,496 | I | ||||||||||||||||
10/1/04 14:51 | 9/29/04 | MYOG | Myogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Alsop Stewart II | MD | T | P.d | 5,579 | 6.50 | 0 | 858 | 26 | 4,204 | I | |||||||||||||||
6/7/04 10:31 | 6/3/04 | INHX | Inhibitex Inc | Health | BioPrd | Biological Products, (No Diag | Alsop Stewart II | MD | T | P | 7,490 | 7.00 | 0 | 1,070 | New | 1,070 | I | ||||||||||||||||
2/24/04 21:52 | 2/20/04 | ARDM | Aradigm Corp | CA | Health | ElcMd | Electromedical & Electrothera | Alsop Stewart II | MD | T | S | -24 | 2.35 | 0 | -10 | -100 | 0 | I | -54 | 167 | 47 | 21 | 5 | -1 | -9 | -5 | -2 | 4 | -1 | -50 | -66 | -46 | |
11/7/03 17:03 | 11/5/03 | PHRM | Pharmion Corp | Health | Drug | Pharmaceutical Preparations | Alsop Stewart II | MD | T | P | 5,600 | 14.00 | 0 | 400 | 10 | 4,341 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |